High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
暂无分享,去创建一个
Stewart T. Cole | Auguste Genovesio | Min Jung Seo | Marie Kempf | Priscille Brodin | Hee Kyoung Jeon | Mary Jackson | Henrieta Škovierová | A. Genovesio | S. Cole | M. Kempf | R. Brosch | L. Marsollier | M. Jackson | U. Nehrbass | H. Skovierová | D. Fenistein | G. Riccardi | P. Brodin | T. Christophe | T. Oh | M. Joly-Guillou | Laurent Marsollier | Roland Brosch | Sunhee Kang | H. Jeon | H. Pham | M. Seo | Saeyeon Lee | Z. No | Jaeseung Kim | Ulf Nehrbass | Denis Fenistein | Marie-Laure Joly-Guillou | Thierry Christophe | E. Park | J. Carralot | Sunhee Kang | Zaesung No | Monica Contreras-Dominguez | Jaeseung Kim | Jean-Philippe Carralot | Fanny Ewann | Eun Hye Kim | Sae Yeon Lee | Eun Jung Park | Ha Pham | Giovanna Riccardi | Ji Youn Nam | Taegwon Oh | Won Kyung Shin | F. Ewann | J. Nam | Mónica Contreras-Dominguez | W. Shin | Auguste Genovesio | Henrieta Skovierová
[1] T Chojnacki,et al. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. , 1994, The Journal of biological chemistry.
[2] S. Cole,et al. Dissection of ESAT-6 System 1 of Mycobacterium tuberculosis and Impact on Immunogenicity and Virulence , 2006, Infection and Immunity.
[3] J. Mittler,et al. A replication clock for Mycobacterium tuberculosis , 2009, Nature Medicine.
[4] Gavin Churchyard,et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. , 2009, The New England journal of medicine.
[5] Peter J. Peters,et al. M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells , 2007, Cell.
[6] B. Wolucka,et al. Biosynthesis of D‐arabinose in mycobacteria – a novel bacterial pathway with implications for antimycobacterial therapy , 2008, The FEBS journal.
[7] S. Franzblau,et al. Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis , 2007, Antimicrobial Agents and Chemotherapy.
[8] L. Bermudez,et al. Mycobacterium tuberculosis invades and replicates within type II alveolar cells , 1996, Infection and immunity.
[9] Pedro M Alzari,et al. Rising standards for tuberculosis drug development. , 2008, Trends in pharmacological sciences.
[10] L. Ramakrishnan,et al. The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection , 2009, Cell.
[11] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[12] M. Perkins,et al. Confronting the scientific obstacles to global control of tuberculosis. , 2008, The Journal of clinical investigation.
[13] L. Fiette,et al. Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes. , 2005, Blood.
[14] Yang Liu,et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages , 2003, The Journal of experimental medicine.
[15] F. Portaels,et al. Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.
[16] G. Besra,et al. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol , 1995, Antimicrobial agents and chemotherapy.
[17] D Fenistein,et al. A fast, fully automated cell segmentation algorithm for high‐throughput and high‐content screening , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[18] S. Khoo,et al. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. , 2007, Tuberculosis.
[19] R. Slayden,et al. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. , 2000, Biochemical pharmacology.
[20] V. Mizrahi,et al. The survival kit of Mycobacterium tuberculosis , 2007, Nature Medicine.
[21] G. Delsol,et al. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells , 2004, Cellular microbiology.
[22] E. Rubin,et al. Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.
[23] J. Abastado,et al. Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells 1 , 2003, The Journal of Immunology.
[24] Clifton E. Barry,et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.
[25] B. Barrell,et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.
[26] P. Brennan,et al. Decaprenylphosphoryl Arabinofuranose, the Donor of the d-Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose , 2005, Journal of bacteriology.
[27] B. Gicquel,et al. Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis. , 2003, Microbiology.
[28] Stewart T. Cole,et al. Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis , 2009, Science.
[29] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[30] D. Russell,et al. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. , 2007, Cell Host and Microbe.
[31] Auguste Genovesio,et al. IM.Grid, a Grid computing approach for Image Mining of High Throughput-High Content Screening , 2008, 2008 9th IEEE/ACM International Conference on Grid Computing.
[32] Brigitte Gicquel,et al. Is Adipose Tissue a Place for Mycobacterium tuberculosis Persistence? , 2006, PloS one.
[33] P. D. Hart,et al. RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.
[34] Pilho Kim,et al. PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release , 2008, Science.
[35] Hinrich W. H. Göhlmann,et al. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.
[36] M. McNeil,et al. Polyprenylphosphate-pentoses in Mycobacteria Are Synthesized from 5-Phosphoribose Pyrophosphate* , 1996, The Journal of Biological Chemistry.